Abstract: A system for measuring fluid absorption and retention properties of various samples having one or more materials, layers and/or articles. The system includes an optically or radiographically transparent fixture. The system enables measuring voxels having a grayscale value that demonstrate a difference in fluid densities and thereby enable the study of fluid flow and movement within and/or amongst various materials and articles in real time.

Abstract: Disclosed is a tampon applicator package assembly having a tampon applicator and a cap having a closed end and an open end. The tampon applicator has a barrel for housing a pledget and a plunger. The plunger has an end portion that is a cap cover that connects to a remainder of the plunger and mates with the cap at the open end to provide a seal with the cap that completely encloses the tampon applicator in the cap. Also disclosed is an assembly having a tampon applicator, a cap having both a closed end and open end, and a cap cover for covering the open end of the cap. When the cap cover is placed on the open end, the open end is sealed and the tampon applicator is completely enclosed in the cap.

Abstract: Disclosed is a tampon applicator package assembly having a tampon applicator and a cap having a closed end and an open end. The tampon applicator has a barrel for housing a pledget and a plunger. The plunger has an end portion that is a cap cover that connects to a remainder of the plunger and mates with the cap at the open end to provide a seal with the cap that completely encloses the tampon applicator in the cap. Also disclosed is an assembly having a tampon applicator, a cap having both a closed end and open end, and a cap cover for covering the open end of the cap. When the cap cover is placed on the open end, the open end is sealed and the tampon applicator is completely enclosed in the cap.

Abstract: A portable UV detection apparatus is disclosed. In one embodiment, the UV detection apparatus includes a UV detection device integrated with a skin type measuring device. A controller can be included in the apparatus that is in communication with the skin type measuring device and the UV detection device. The controller can provide information to the user regarding the amount of ultraviolet radiation present in the environment. In an alternative embodiment, the UV detection apparatus includes a UV detection device in conjunction with a light sensor. The light sensor can be configured to activate the UV detection device should light at a particular intensity be present in the environment. The UV detection device as described above can be configured to measure UVA radiation, UVB radiation, and/or UVC radiation.

Abstract: An instrument monitoring system comprises a monitoring device including a sensor for measuring an instrument and a control unit, where the control unit includes a data flow microcontroller processor; a wireless transmitter configured to receive a data signal from the monitoring device and to transmit the data signal using a wireless data transmission protocol; a wireless reader capable of receiving the data signal from the wireless transmitter; a computing device in communication with the wireless reader, where the computing device includes software configured to present the data signal as user-readable data; and a computer-readable storage medium in communication with the computing device, wherein the computer-readable storage medium is capable of storing the data.

Abstract: Embodiments of the invention provide virtual reality tools and simulations used for improved health care customer management. The virtual reality tools may be used by a product manufacturer or seller to assist in relationship management with health care partners including identifying improved solutions for a variety of problems, strengthening infection prevention processes and systems, improving order and flow in the operating room and other care-delivery environments, identifying benefits from new products, providing techniques for evaluating new health care systems and processes, etc.

Abstract: Embodiments of the invention provide virtual reality tools used to develop improved infection control solutions. The virtual reality tools may be applied to a variety of health care environments to develop improved infection control solutions, including improved training systems for modifying human behavior regarding hand washing (or other infection control behaviors), improved systems for evaluating the effectiveness of a proposed infection control solution, and for a producer/seller of anti-microbial products to demonstrate the superiority of one product over another or the superiority of one proposed solution over another.

Abstract: An audio sensor and receiver detect, discriminate and count the number of liquid swallows to determine the volume of fluid ingested.

Abstract: A portable UV detection apparatus is disclosed. In one embodiment, the UV detection apparatus includes a UV detection device integrated with a skin type measuring device. A controller can be included in the apparatus that is in communication with the skin type measuring device and the UV detection device. The controller can provide information to the user regarding the amount of ultraviolet radiation present in the environment. In an alternative embodiment, the UV detection apparatus includes a UV detection device in conjunction with a light sensor. The light sensor can be configured to activate the UV detection device should light at a particular intensity be present in the environment. The UV detection device as described above can be configured to measure UVA radiation, UVB radiation, and/or UVC radiation.

Abstract: The present invention relates to methods, compounds, and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses, and is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention also relates to compounds that inhibit smooth muscle proliferation, for example, by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis. This invention also relates to medical devices, such as a stent, comprising a compound or composition of this invention disposed on or within the medical device.

Abstract: The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Abstract: The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Abstract: The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Abstract: The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Abstract: The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Abstract: The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

Abstract: The present invention discloses a disposable cleaning product for use in household cleaning or personal care applications. The cleaning product of the invention is a multi-layer laminate product and may include at least two distinct layers, an abrasive layer and an absorbent layer. The absorbent layer contains a sponge-like member optionally in combination with a plurality of cellulosic fibrous webs. The sponge-like member can be made from various materials. For example, in one embodiment, the sponge-like member comprises one or more layers of a spunbond web containing crimped, bicomponent filaments.

Abstract: The present invention relates to disposable absorbent articles that include absorbent systems. The absorbent system includes an absorbent pad formed of absorbent materials and having a lateral direction and a longitudinal direction. The absorbent pad has a narrow zone area of increased thickness of absorbent materials that has a length greater than or equal to 80% of the length of the absorbent pad. The narrow zone area has a width in the lateral direction of the absorbent pad that is less than or equal to 62% and greater than or equal to 20% of the width of a non-zone area.

Abstract: The present invention relates to triazine compounds and their analogs and derivatives, and methods and compositions comprising these compounds. The compounds and compositions of this invention are useful for, among other things, treating pathophysiological conditions arising from inflammatory responses, inhibiting or blocking glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells, inhibiting smooth muscle proliferation, treating vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis, and the like.

Abstract: The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.